193 related articles for article (PubMed ID: 11535321)
1. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.
Joines RW; Blatter M; Abraham B; Xie F; De Clercq N; Baine Y; Reisinger KS; Kuhnen A; Parenti DL
Vaccine; 2001 Sep; 19(32):4710-9. PubMed ID: 11535321
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
Burgess MA; Rodger AJ; Waite SA; Collard F
Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
[TBL] [Abstract][Full Text] [Related]
3. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].
Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135
[TBL] [Abstract][Full Text] [Related]
4. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
Guptan RC; Thakur V; Safary A; Sarin SK
Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
[TBL] [Abstract][Full Text] [Related]
9. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
Van Der Wielen M; Van Damme P; Collard F
Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
[TBL] [Abstract][Full Text] [Related]
10. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
[TBL] [Abstract][Full Text] [Related]
11. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
15. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
[TBL] [Abstract][Full Text] [Related]
16. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.
Murdoch DL; Goa K; Figgitt DP
Drugs; 2003; 63(23):2625-49. PubMed ID: 14636084
[TBL] [Abstract][Full Text] [Related]
17. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers.
Reutter J; Bart PA; Francioli P; Safary A; Frei PC
J Viral Hepat; 1998 May; 5(3):205-11. PubMed ID: 9658375
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Twinrix in older adults: a critical analysis.
Stoffel M; Lievens M; Dieussaert I; Martin I; André F
Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]